Skip to main content
Journal of Clinical Medicine logoLink to Journal of Clinical Medicine
. 2024 Jul 19;13(14):4208. doi: 10.3390/jcm13144208

Systematic Review of Executive Function Stimulation Methods in the ADHD Population

Carlos Ramos-Galarza 1,*, Deyaneira Brito 1, Brayan Rodríguez 1, Brenda Guerrero 1, Jorge Cruz-Cárdenas 2, Mónica Bolaños-Pasquel 3
Editor: Marios Adamou
PMCID: PMC11278469  PMID: 39064248

Abstract

Background/Objectives: Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by elevated motor activity, impulsivity, and attention deficit. Approximately 5% of the population suffers from this disorder. Among the key explanations of ADHD, executive functions play an important role in understanding the symptomatology present in this disorder and in determining the main treatment strategies for affected patients. We present a systematic review that seeks to identify the treatment methods developed to support executive functions in individuals with ADHD. Methods: Articles were analyzed in the SCOPUS, PUBMED, and Science Direct databases. Initially, 739 articles were found. After applying inclusion and exclusion criteria, 30 articles remained and were included in the data extraction process. Results: Among the primary treatments identified, 14 studies propose psychological training for executive functions, 9 studies recommend medication, 5 studies suggest digital interventions, and 1 study advocates for sports as beneficial for executive functions. Conclusions: The data are discussed around the need to develop new proposals to enhance the executive functions of individuals with ADHD, thereby improving their performance in educational, personal, social, and family activities impacted by this disorder.

Keywords: attention deficit hyperactivity disorder, executive functions, treatment

1. Introduction

ADHD is a neurodevelopmental disorder characterized by persistent patterns of inattention, hyperactivity, and impulsivity. These symptoms often manifest in childhood and can persist into adolescence and adulthood [1]. The global prevalence of ADHD ranges from 5.9% to 7.1% in children and 1.2% to 7.3% in adults, indicating its significant impact across different age groups [2,3].

However, prevalence rates of ADHD can vary based on ethnic differences. Contrary to previous beliefs, recent studies contradict the notion that the prevalence of ADHD is lower in certain ethnic groups. For instance, while it was once thought that Black children and adolescents had lower rates of ADHD compared to their White counterparts, research has shown that the prevalence rates between these groups do not significantly differ [4]. Moreover, Asian and Latino children and adolescents tend to present lower prevalence rates of ADHD than both their Black and White counterparts. These differences may be influenced by factors such as access to healthcare, socioeconomic status, and cultural attitudes toward mental health [5].

ADHD is a disorder of multifactorial origin, with the following most commonly described causal factors in the literature: genetic predispositions, gestational and perinatal factors, and environmental influences [2]. Changes in brain structure and function are observed in individuals with ADHD, affecting mechanisms such as neurogenesis and synaptogenesis, which, in turn, disrupt attention and impulse control, core functions regulated by the central nervous system [3]. The etiology of ADHD is diverse, with interactions between genetic and environmental factors contributing to the heterogeneous manifestation of the disorder among individuals and subsequently influencing their response to interventions [6].

This disagreement on the causes can contribute to a clash in treatment processes, which, in turn, impacts both academic and familial spheres. In the academic realm, for instance, children with ADHD may struggle to concentrate, follow instructions, and complete tasks, thereby affecting their academic performance and self-esteem [7]. Within the family, the lack of understanding about the nature of the disorder can generate stress and frustration, increasing tensions at home. This situation will affect the support networks available to a child with ADHD in their close environment since the specific needs of this population require collaborative efforts [8].

Individuals diagnosed with ADHD can encounter several challenges in their daily lives across various domains. In childhood and adolescence, ADHD can significantly impact academic achievement, social interactions, and overall well-being. Symptoms of ADHD, such as inattention and hyperactivity, often persist into adolescence, leading to difficulties in peer relationships, academic performance, and behavioral challenges. An estimated 72% of adolescents with ADHD present with sleep problems [9,10]. This affects their daytime functioning and exacerbates symptoms of inattention and hyperactivity. Moreover, untreated ADHD in adolescence increases susceptibility to risky behaviors, substance misuse, and mental health issues, including depression [11,12,13].

In adulthood, individuals with ADHD can face occupational challenges, educational impairments, financial difficulties, and family instability [14]. They are less likely to graduate from high school and college, have lower job stability, and demonstrate impaired job performance. ADHD also contributes to higher rates of substance abuse, mental health disorders, and financial stress, leading to increased reliance on public aid and decreased income [15,16].

Moreover, individuals with ADHD often experience comorbid conditions, such as anxiety disorders, significantly higher than the general population [17]. Anxiety symptom severity is associated with lower social skills and higher social problems in young people with ADHD, exacerbating existing social difficulties. Additionally, challenges with emotional regulation are common among individuals with ADHD, characterized by difficulties in managing and expressing emotions effectively. Studies indicate that adults with ADHD exhibit lower emotional regulation scores compared to controls, utilizing non-adaptive emotion regulation strategies such as self-blame and rumination. Emotional dysregulation is associated with greater socio-functional impairment, impacting relationships, stress management, and coping abilities. Addressing comorbid conditions and emotional regulation challenges is crucial for comprehensive support and intervention to mitigate the impact of ADHD [18,19].

One of the most widely accepted theories explaining the essential cause of ADHD symptomatology states that children, adolescents, or adults with this disorder present an immature executive function development [20]. Executive functions are a set of high-level mental abilities that help us plan, organize, and control behavior to achieve goals [21]. There is no specific number of executive functions and there are proposals that consider them as a single factor or multiple skills that interact to achieve behavioral regulation [22]. Different authors propose that there are different executive functions: inhibitory control, working memory, planning, verification, decision-making, emotional regulation, and cognitive flexibility [23,24,25].

In ADHD, the main executive function that is thought to be affected is inhibitory control. This impairment generates a domino effect, causing difficulties with working memory capacity, internal language regulating behavior, reconstitution of new behaviors, regulation of emotion, and arousal and motivation [26]. This alteration of the executive functions is what causes ADHD to present as a lack of regulation of behavior and cognition. This generates problems affecting individuals diagnosed with this disorder in different spheres, such as the educational, family, personal, social, work, and others [27,28,29].

The need to work on executive functions in ADHD is a crucial aspect of the management of this neurodevelopmental disorder. Over the years, various strategies have been explored to address these functions, which play a fundamental role in the regulation of behavior, attention, planning, and decision-making in individuals with ADHD. Among the most common interventions is the use of stimulant medications such as psychostimulants, which have been shown to improve attention and reduce hyperactive and impulsive symptoms in many patients. However, while these medications may be effective for some individuals, they are not a definitive solution as they do not directly address executive function deficits [30].

Another important approach is cognitive behavioral therapy (CBT), which focuses on identifying and changing dysfunctional patterns of thinking and behavior. CBT can be beneficial in improving skills such as self-regulation, problem-solving, and organization, which are directly related to executive functions. In addition, neuropsychological therapy, which focuses on rehabilitating specific areas of cognitive functioning, shows great potential for the treatment of ADHD. Through activities designed to improve working memory, cognitive flexibility, and inhibitory control, we seek to strengthen executive functions and improve overall functioning [31].

However, despite advances in these approaches, there is still no clear consensus on what is the best strategy for addressing impaired executive functions in ADHD. Research has shown mixed results leaving as a consequence many unanswered questions. Therefore, it is crucial to conduct a systematic review that integrates the most recent findings and evaluates the relative effectiveness of various interventions that address executive functions in people with ADHD.

This review could help inform clinical practice and guide the development of more effective and personalized future research that addresses the specific needs of each individual with ADHD. In addition, it would highlight the importance of further research in this field to improve the quality of life and functioning of individuals affected by this disorder.

2. Materials and Methods

The scope of this research focuses on analyzing systematic reviews by applying the PRISMA method [32]. The first stage involved identifying the research question and proceeding with data collection. Initially, a total of N = 739 articles were obtained. In the second stage, duplicate articles (N = 285) were identified and excluded. In the third stage, the remaining articles were assessed according to the inclusion criteria (human participation, treatment to improve executive functions, people diagnosed with ADHD, and articles in English and Spanish) and exclusion criteria (languages other than Spanish and English, systematic reviews, books or theses, paid access, or articles that proposed interventions not aimed at improving executive functions in ADHD), resulting in the exclusion of N = 406 articles. Consequently, in the fourth stage, a selection of N = 32 articles was made and used in this research. In the fifth stage, the statistical analysis is presented. Finally, in the sixth stage, the summary collation and dissemination of the results are carried out through the application of the analytical framework (Figure 1).

Figure 1.

Figure 1

Flowchart of the systematic review conducted.

To achieve our research objective, we used the following databases: SCOPUS, Science Direct, and PUBMED using the keywords: executive functions, ADHD, treatment, and intervention, with the respective Boolean terms (OR, AND). During the research process, three reviewers supervised: titles, abstracts, and full texts considering the inclusion and exclusion criteria, thus accepting, or rejecting the discrepancies found in the papers. Consequently, each independent article was combined into a single file, thus adopting the results of the three reviewers by extracting the files with different results. The extraction table included data such as authors, research design, year of publication, the sample size used, type of intervention, intervention time, country of application, tests applied to assess executive functions, and results, among others. This investigation has been registered in the PROSPERO platform under the number 557,233. This information is presented in Appendix A.

3. Results

The process to obtain the results involved a series of meticulous steps that allowed for a comprehensive analysis and understanding of the data. Firstly, dynamic tables were used to organize the data in a structured manner. These tables provide a dynamic view of the items for each variable, facilitating the identification of patterns and key relationships among the data. Subsequently, specific ranges were generated to perform detailed and segmented tabulations of the results. These ranges enabled us to group similar data and establish relevant categories for deeper analysis. Once the data were organized and analyzed, the results were visualized through charts. These charts were designed to visually represent the trends and relationships identified in the data, thus facilitating their interpretation.

Furthermore, key statistical measures, such as mean and standard deviation, were calculated for both subjects with ADHD for adults and children participating in the study. These measures provided us with a deeper understanding of the central tendency and dispersion of the data, enriching our analysis and conclusions. In summary, the process of obtaining results was a combination of descriptive and visual data analysis techniques that allowed us to explore and understand our research findings in depth.

3.1. Research Design

Feasibility studies, preliminary studies, and randomized controlled trials (RCTs) were the main research designs we encountered. RCTs stood out as the most prevalent. Check out Figure 2 to see their prominence.

Figure 2.

Figure 2

Research designs of the articles reviewed.

3.2. Research Countries

China leads with 7 studies, followed by the United States with 5 and Norway with 4, among other countries. Discover this distribution of studies in Figure 3.

Figure 3.

Figure 3

Research in countries.

3.3. Participants Stage

In terms of the life stage of individuals who underwent treatment, there were 21 studies involving children, followed by 7 studies in adults. Additionally, 2 studies encompassed adolescents and a combination of children and adolescents. These data are presented in Figure 4.

Figure 4.

Figure 4

Subjects’ stage.

3.4. Treatment Implemented

In the articles, various treatments were implemented to improve executive functions in individuals diagnosed with ADHD. The primary treatments included methylphenidate and mindfulness, followed by transcranial anodal direct current stimulation and viloxazine, among others. Psychological treatments were predominantly used, featured in 14 studies, followed by medication in 9 studies. Conversely, treatments such as polyamines and sports received the lowest number of studies. This distribution is visualized in Figure 5.

Figure 5.

Figure 5

Treatment Type.

3.5. Test Administered in Previous Research

In the articles, various tests were administered, with the BRIEF used in 6 studies and the Stroop test used in 3 studies. These tests were used to identify the presence of ADHD and assess executive functions. Explore Figure 6 to visualize the distribution of these tests across the studies.

Figure 6.

Figure 6

Test implemented.

3.6. Intervention Time

There were four ranges used to identify the intervention duration of treatments in days. The range of 0–182 days included 21 studies, followed by 183–365 days and 731 days or more, each with 4 studies, and finally, 549–730 days with 1 study. Explore Figure 7 to visualize the distribution of treatment durations across the studies.

Figure 7.

Figure 7

Implemented time in days.

3.7. Improved Executive Functions

In the analysis of the results, there was evidence of improvement in executive functions, although not uniformly across all aspects. Notably, working memory demonstrated the highest score in 15 studies, followed by inhibition in 12 studies, and cognitive flexibility in 5 studies. However, processing speed and sustained attention showed the lowest scores, each with only 1 study. To identify the efficacy of the treatment received with executive functions, a significant association was found between improving executive functioning and the type of psychological treatment (x2 = 11.82, p = 0.03). Explore these findings further in Figure 8.

Figure 8.

Figure 8

Improvement of executive functions.

4. Discussion

ADHD is a neurodevelopmental disorder that affects the normal development of children, adolescents, and adults. It is one of the most prevalent mental health problems. For this reason, it is vital to continue the dialogue on this matter and its treatment processes, which currently lack consensus on proposals or results [33,34].

Within the context of this article, the research based on a quantitative systematic review of treatment methods for executive functions in the ADHD population is presented. The importance of research on executive functions lies in the central role played by skills, such as inhibitory control, working memory, emotional regulation, cognitive flexibility, and planning in understanding the problems with the regulation of behavior and cognition that occur in this disorder [20,26].

The research began with 739 articles, and after analyzing the inclusion and exclusion criteria, 32 studies were included, allowing for the planned analyses to be carried out. The main results identified that randomized controlled trials were the most frequently performed research design. Regarding the temporality of studies, it was found that the last 5 years represent the highest scientific production in this line of research. Regarding the location of the research, it was found that the largest number of studies were conducted in Europe. As for the developmental level at which most studies were carried out, it was during childhood. The most frequently used treatment to support executive functions in ADHD was psychological interventions. The executive functions that benefit most from the identified treatments are working memory, inhibition, and cognitive flexibility. This study contributes to the understanding of ADHD by confirming the importance of executive functions when conducting interventions with individuals with this disorder. As previously mentioned, the roles of functions such as inhibitory control, working memory, and cognitive flexibility are crucial for individuals with ADHD to improve their behavioral regulation skills.

The findings of this systematic review underscore the breadth of research exploring interventions for ADHD, with particular emphasis on supporting executive functions, which tend to be affected by this neurodevelopmental disorder. Notably, both psychological interventions and pharmacotherapy have received substantial attention. For clinicians and healthcare providers navigating treatment options for individuals with ADHD, a thorough consideration of the available evidence must be conducted. Moreover, tailoring interventions to suit the developmental stage of the patient is essential to ensure the benefits seen in the patient’s quality of life. Furthermore, the combination of interventions, such as medication and psychological therapies, needs careful examination to ensure efficacy is grounded in empirical evidence.

Beyond treatment modalities, the cultural context emerges as a pivotal factor influencing intervention success. While existing research predominantly emanates from North America, Europe, and Asia, it is imperative to acknowledge and address the diversity of cultural backgrounds among individuals seeking treatment worldwide. Adapting interventions to local contexts is crucial for their applicability and efficacy [35,36,37]. This adaptation process necessitates not only clinical adjustments but also rigorous research to elucidate the specific cultural nuances that impact treatment engagement and effectiveness [38,39,40,41]. As such, bridging the gap between research and practice entails a comprehensive understanding of the multifaceted influences shaping the experiences of individuals with ADHD across diverse cultural landscapes.

Future research motivates us to develop our own intervention for executive functions in the ADHD population. Our interest lies in technological aspects that may be useful, especially for children and adolescents with the disorder. Finally, it is essential to continue studying executive functions, as these high-level mental abilities are not only affected in ADHD but also in other pathologies that affect human mental and behavioral activity and their pharmacological, non-pharmacological, and multimodal treatments [41,42,43,44,45,46,47,48,49,50,51].

The main limitation of this research lies in the lack of access to all the published articles, as several documents required payment to download. Another aspect is the language delimitation, as we only worked with studies published in English and Spanish; however, in future studies, we will review works published in other languages to cover the largest number of works on ADHD.

Appendix A

Table A1.

Information Extraction Table.

Title Country Authors Sample Size Used Subjects with ADHD Stage Treatment Used Type of Treatment Test Implemented Intervention Time/Days Which Executive Functions are Improvement
Clinical and cognitive correlates of childhood attention-deficit/hyperactivity disorder in first-episode psychosis: a controlled study Spain Sánchez-Gistau et al.
[52]
133 68 Children Emotional stabilizers
Antidepressants
Antipsychotics
Medication MCCB
TMT-A
NAB
1641 All
Dialectical behavioral therapy-based group treatment versus treatment as usual for adults with attention-deficit hyperactivity disorder: a multicenter randomized controlled trial Norway Halmøy et al. [53] 121 121 Adults Mindfulness
Dbt-bgt
Psychological BRIEF
DERS
98 All
Device-based movement behaviors, executive function, and academic skills among African-American children with ADHD and disruptive behavior disorders United States Santiago et al. [54] 42 23 Children Af vigorosa Psychological BRIEF
CBM
AWMA-short version
7 None
Differential long-term medication impact on executive function and delay aversion in ADHD Spain Rubio and Hernández [55] 58 26 Children Mph
Atx
Psychological K-BIT test
Test automated battery cantabeclipsetm
273 Working memory
Decision making
Inhibition
Planning
Cognitive flexibility
Verbal fluency
Effect of game-based high-intensity interval training program on the executive function of children with ADHD: protocol of a randomized controlled trial China Sun et al. [56] 42 42 Children Gamehiit
Games
Serious games CWST
CBTT
Octamon fNIRS system
TLT
60 Working memory
Inhibition
Planning
Sustained attention
Cognitive flexibility
Transcranial direct current stimulation as an effective treatment compared to video games on executive functions in children with attention deficit hyperactivity disorder India Makkar et al. [57] 61 61 Children Tdcs along with video game
Video game only
Serious games TMT-A
Raven progressive matrices
30 Working memory
Cognitive flexibility
Inhibition
Verbal fluency
Effectiveness of online mindfulness-based intervention (imbi) on inattention, hyperactivity-impulsivity, and executive functioning in college emerging adults with attention-deficit/hyperactivity disorder: a study protocol China Pheh, et al. [58] 108 54 Adults Mindfulness Psychological ASRS
ADEXI
56 None
Effects of combing group executive functioning and online parent training on school-aged children with ADHD: a randomized controlled trial China Chu et al. [59] 145 145 Children Gef-opt Psychological SNAP-IV
BRIEF
Go/no-go task
WFIRS-P
30 Inhibition
Planning
Working memory
Effects of methylphenidate on executive functioning in children and adolescents with ADHD after long-term use: a randomized, placebo-controlled discontinuation study Norway Rosenau et al. [60] 94 94 Children and adolescents Methylphenidate Medication Neuropsychological assessment 49 Working memory
Effects of agmatine, glutamate, arginine, and nitric oxide on executive functions in children with attention deficit hyperactivity disorder Türkiye Sarl et al. [61] 35 35 Children Elisa Medication Stroop test
TMT
365 None
Efficacy of cognitive behavioral therapy in medicated adults with attention-deficit/hyperactivity disorder in multiple dimensions: a randomized controlled trial China Pan et al. [62] 98 98 Adults Methylphenidate Medication Cantab
Regarding executive function
84 Inhibition
An empirical examination of executive functioning, ADHD associated behaviors, and functional impairments in adults with persistent ADHD, remittentADHD, and without ADHD Spain Roselió et al. [63] 61 61 Adults Image Psychological CAARS
BRIEF
BRI
MI
WFIRS-P
1460 Inhibition
Working memory
Planning
Executive function and attention performance in children with ADHD: effects of medication and comparison with typically developing children Hungary Miklós et al. [64] 168 50 Children Medication Medication Kitap testing
Mini kid
730 Attentional control
Inhibition
Executive function measured by brief in adolescents diagnosed and treated for ADHD: problem profiles and agreement between informants Norway Andersen et al. [65] 100 100 Adolescents Tcc Psychological Kiddie-sads-pl
Ksads-pl
1095 Working memory
Planning
Executive function outcome of treatment with viloxazine extended-release capsules in children and adolescents with attention-deficit/hyperactivity disorder: a post-hoc analysis of four randomized clinical trials United States Faraone et al. [66] 1154 605 Children and adolescents Viloxazine Medication Cgi-s
Mmrm
56 All
Iamhero: preliminary findings of an experimental study to evaluate the statistical significance of an intervention for ADHD conducted through the use of serious games in virtual reality Italy Schena et al. [67] 60 60 Children Iamhero Serious games Wisc-iv
Bia
Tol
42 Planning
Attentional control
Decision making
Feasibility, acceptability, and effectiveness of a new cognitive-behavioral intervention for college students with ADHD United States Solanto et al. [68] 19 19 Adolescents Transcranial anodal direct current stimulation Psychological Home exercise 84 Working memory
Cognitive flexibility
Improved executive function in adults diagnosed with attention-deficit/hyperactivity disorder as measured by the brown attention-deficit disorder scale following treatment with shp465 mixed amphetamine salts extended-release: post hoc analyses from 2 randomized, placebo-controlled studies United States Brown et al. [69] 673 673 Adults Shp465 mas Medication Badds 42 Attentional control
Impacts of soccer on executive function in boys with ADHD China Chen [70] 968 968 Children Soccer practice intervention Sport Control pretest
Working memory pretest
Cognitive flexibility pretest
42 Cognitive flexibility
Inhibition
Influence of methylphenidate on long-term neuropsychological and everyday executive functioning after traumatic brain injury in children with secondary attention problems United States Leblond et al. [71] 26 26 Children Methylphenidate Medication BRIEF
CPT-II
D-KEFS VF
WISC-IV
168 Processing speed
Attentional control
Mindfulness training for children with ADHD and their parents: a randomized control trial Spain Valero et al. [72] 30 30 Children My mind program Psychological CONNERS
WISC-IV
NEPSY-II
168 Cognitive flexibility
Working memory
Osmotic release oral system-methylphenidate hydrochloride (oros-mph) versus atomoxetine on executive function improvement and clinical effectiveness in ADHD: a randomized controlled trial Türkiye Torun et al. [73] 135 95 Children Oros-mph Medication KSADS-PL
CTRS
Stroop test
Cancelation test
126 None
Perceptual-motor skills reconstruction program improves executive functions in children with attention-deficit/hyperactivity disorder Iran Kouhbanani and Rothenberger [74] 50 50 Children The perceptual-motor skills reconstruction program Psychological Demographic profile
Clinical interview
Conner’s parent rating scale-revised
Delis-Kaplan executive function system
168 Cognitive flexibility
Inhibition
Verbal fluency
Working memory
Parental occupation executive training (poet): an efficient innovative intervention for young children with attention deficit hyperactive disorder Israel Frisch et al. [75] 72 72 Children Copm Psychological CPRS
CTRS
CHAS-P
84 Inhibition
Working memory
The potential effectiveness of digital therapeutics specialized in executive functions as an adjunctive treatment for clinical symptoms of attention-deficit/hyperactivity disorder: a feasibility study South Korea Sun et al. [76] 30 27 Children Nurow Digital therapeutic interventions CAT
PSYTOOLKIT
CBCL
28 None
Predictors and moderators of treatment outcome in cognitive training for children with ADHD Norway van der donk et al. [77] 98 98 Children Cwmt
Pac
Psychological LDS
ODD
25 Working memory
Randomized control study of the effects of executive function training on peer difficulties of children with attention-deficit/hyperactivity disorder c subtype China Lan et al. [78] 96 96 Children Geft
Sst
Psychological SAICA
CPT-II
WCST
Adhd rating scale-iv
Raven’s progressive matrices
84 Working memory
Cognitive flexibility
Response inhibition and interference control in adult attention deficit hyperactivity disorder Türkiye Çelik et al. [79] 85 42 Adults Neuropsychological Psychological Stroop test
Bis-11
Ibm spss version 23.0
Sst
1095 Inhibition
Scaffolding the attention-deficit/hyperactivity disorder brain using transcranial direct current and random noise stimulation: a randomized controlled trial Israel Berger et al. [80] 19 19 Children Transcranial electrical stimulation
Computerized of training
Digital therapeutic interventions TDCS
DLPFC
365 Working memory
Safety and efficacy of guanfacine extended-release in adults with attention deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study Japan Iwanami et al. [81] 150 150 Adults Grx Medication CAARS
CGI-I
BRIEF
350 Working memory
Randomized controlled study on the effect of multimodal therapy and drug therapy on children with attention deficit hyperactivity disorder China Qian et al. [82] 61 61 Children Medicine and Psychological treatment Multimodal Treatment SNAP
STROOP
WCST
360 Working Memory
Inhibition
Moderating role of individual and familial characteristics in the improvement of organizational skills ADHD Youths’ participation in the TRANSITION project Canada Girars-Lapointe et al. [83] 70 70 Children Medicine and Psychological treatment Multimodal Treatment DISC-IV
Conners
WISC-IV
270 Planning
Working Memory
Organization

Author Contributions

Conceptualization, C.R.-G. and M.B.-P.; methodology, C.R.-G., D.B., B.R., B.G. and J.C.-C.; software, M.B.-P.; validation, C.R.-G., M.B.-P. and J.C.-C.; formal analysis, C.R.-G.; investigation, D.B., B.R. and C.R.-G.; resources, M.B.-P.; data curation, J.C.-C.; writing—original draft preparation, C.R.-G., D.B. and B.R.; writing—review and editing, C.R.-G. and B.G.; funding acquisition, C.R.-G. All authors have read and agreed to the published version of the manuscript.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Conflicts of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest.

Funding Statement

This research was funded by Pontificia Universidad Católica del Ecuador; Grant number: QINV0468-IINV531010200.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

  • 1.Núñez-Jaramillo L., Herrera-Solís A., Herrera-Morales W.V. ADHD: Reviewing the causes and evaluating solutions. J. Pers. Med. 2021;11:166. doi: 10.3390/jpm11030166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Huss M., Duhan P., Gandhi P., Chen C.-W., Spannhuth C., Kumar V. Methylphenidate dose optimization for ADHD treatment: Review of safety, efficacy, and clinical necessity. Neuropsychiatr. Dis. Treat. 2017;13:1741–1751. doi: 10.2147/NDT.S130444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Thomas R., Sanders S., Doust J., Beller E., Glasziou P. Prevalence of attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. Pediatrics. 2015;135:e994–e1001. doi: 10.1542/peds.2014-3482. [DOI] [PubMed] [Google Scholar]
  • 4.Musella K.E., Weyandt L.L. Attention-deficit hyperactivity disorder and youth’s emotion dysregulation: A systematic review of fMRI studies. Appl. Neuropsychol. Child. 2022;12:353–366. doi: 10.1080/21622965.2022.2119142. [DOI] [PubMed] [Google Scholar]
  • 5.Cénat J.M., Kokou-Kpolou C.K., Blais-Rochette C., Morse C., Vandette M.-P., Dalexis R.D., Darius W.P., Noorishad P.-G., Labelle P.R., Kogan C.S. Prevalence of ADHD among Black Youth Compared to White, Latino and Asian Youth: A Meta-Analysis. J. Clin. Child Adolesc. Psychol. 2022;53:373–388. doi: 10.1080/15374416.2022.2051524. [DOI] [PubMed] [Google Scholar]
  • 6.Rusca-Jordán F., Cortez-Vergara C. Attention Deficit and Hyperactivity Disorder in children and adolescents. A clinical review. Rev. Neuropsiquiatr. 2020;83:148–156. doi: 10.20453/rnp.v83i3.3794. [DOI] [Google Scholar]
  • 7.Scandar M. Relación entre los síntomas de TDAH y el aprendizaje escolar en niños preescolares argentinos. Rev. Neuropsicol. Latinoam. 2013;5:11–23. doi: 10.5579/rnl.2013.0139. [DOI] [Google Scholar]
  • 8.Machado M., Sampayo M., Hernández M., Luis M. Guidance for families of hyperactive children to enhance their individual development. Humanidades Médicas. 2022;22:301–310. [Google Scholar]
  • 9.Langberg J.M., Molitor S.J., Oddo L.E., Eadeh H.-M., Dvorsky M.R., Becker S.P. Prevalence, Patterns, and Predictors of Sleep Problems and Daytime Sleepiness in Young Adolescents with ADHD. J. Atten. Disord. 2017;24:509–523. doi: 10.1177/1087054717690810. [DOI] [PubMed] [Google Scholar]
  • 10.Marten F., Keuppens L., Baeyens D., Boyer B.E., Danckaerts M., Cortese S., Van der Oord S. Sleep parameters and problems in adolescents with and without ADHD: A systematic review and meta-analysis. JCPP Adv. 2023;3:e12151. doi: 10.1002/jcv2.12151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Austgulen A., Skram N.K.G., Haavik J., Lundervold A.J. Risk factors of suicidal spectrum behaviors in adults and adolescents with attention-deficit/hyperactivity disorder—A systematic review. BMC Psychiatry. 2023;23:612. doi: 10.1186/s12888-023-05099-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Eccleston L., Williams J., Knowles S., Soulsby L. Adolescent experiences of living with a diagnosis of ADHD: A systematic review and thematic synthesis. Emot. Behav. Difficulties. 2018;24:119–135. doi: 10.1080/13632752.2019.1582762. [DOI] [Google Scholar]
  • 13.Rios-Davis A., Sibley M.H., Delgado A., Zulauf-McCurdy C. Identifying Common and Unique Elements of Evidence-Based Treatments for Adolescent ADHD. J. Child Fam. Stud. 2022;32:466–480. doi: 10.1007/s10826-022-02475-y. [DOI] [Google Scholar]
  • 14.Soler-Gutiérrez A.-M., Pérez-González J.-C., Mayas J. Evidence of emotion dysregulation as a core symptom of adult ADHD: A systematic review. PLoS ONE. 2023;18:e0280131. doi: 10.1371/journal.pone.0280131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Elbe P., Bäcklund C., Vega-Mendoza M., Sörman D., Gavelin H.M., Nyberg L., Ljungberg J.K. Computerized cognitive interventions for adults with ADHD: A systematic review and meta-analysis. Neuropsychology. 2023;37:519–530. doi: 10.1037/neu0000890. [DOI] [PubMed] [Google Scholar]
  • 16.Gordon C.T., Fabiano G.A. The Transition of Youth with ADHD into the Workforce: Review and Future Directions. Clin. Child Fam. Psychol. Rev. 2019;22:316–347. doi: 10.1007/s10567-019-00274-4. [DOI] [PubMed] [Google Scholar]
  • 17.Bishop C., Mulraney M., Rinehart N., Sciberras E. An examination of the association between anxiety and social functioning in youth with ADHD: A systematic review. Psychiatry Res. 2019;273:402–421. doi: 10.1016/j.psychres.2019.01.039. [DOI] [PubMed] [Google Scholar]
  • 18.Chutko L.S., Yakovenko E.A., Surushkina S.Y., Anisimova T.I., Sergeev A.V., Didur M.D., Cherednichenko D.V. Impairments to Emotional and Behavioral Regulation in Children with Attention Deficit Hyperactivity Disorder. Neurosci. Behav. Physiol. 2023;53:40–46. doi: 10.1007/s11055-023-01389-6. [DOI] [Google Scholar]
  • 19.French B., Sayal K., Daley D. Barriers and facilitators to understanding of ADHD in primary care: A mixed-method systematic review. Eur. Child Adolesc. Psychiatry. 2018;28:1037–1064. doi: 10.1007/s00787-018-1256-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ramos-Galarza C., Pérez-Salas C. Moderator Role of Monitoring in the Inhibitory Control of Adolescents With ADHD. J. Atten. Disord. 2018;25:188–198. doi: 10.1177/1087054718776478. [DOI] [PubMed] [Google Scholar]
  • 21.Zhou Z., Yan Y., Gu H., Sun R., Liao Z., Xue K., Tang C. Dopamine in the prefrontal cortex plays multiple roles in the executive function of patients with Parkinson’s disease. Neural Regen. Res. 2023;19:1759–1767. doi: 10.4103/1673-5374.389631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ramos-Galarza C., Acosta-Rodas P., Bolaños-Pasquel M., Lepe-Martínez N. The role of executive functions in academic performance and behaviour of university students. J. Appl. Res. High. Educ. 2019;12:444–455. doi: 10.1108/JARHE-10-2018-0221. [DOI] [Google Scholar]
  • 23.Diamond A. Executive Functions. Annu. Rev. Psychol. 2013;64:135–168. doi: 10.1146/annurev-psych-113011-143750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Friedamn N., Miyake A. Unity and diversity of executive functions: Individual differences as a window on cognitive structure. Cortex. 2017;86:186–204. doi: 10.1016/j.cortex.2016.04.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ramos-Galarza C., Cruz-Cárdenas J., Bolaños-Pasquel M., Acosta-Rodas P. Factorial Structure of the EOCL-1 Scale to Assess Executive Functions. Front. Psychol. 2021;12:585145. doi: 10.3389/fpsyg.2021.585145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Antshel K., Barkley R. Handbook of Clinical Neurology. Volume 174. Elsevier; Amsterdam, The Netherlands: 2020. Attention deficit hyperactivity disorder; pp. 37–45. [DOI] [PubMed] [Google Scholar]
  • 27.Li Y., Ma S., Zhang X., Gao L. ASD and ADHD: Divergent activating patterns of prefrontal cortex in executive function tasks? J. Psychiatr. Res. 2024;172:187–196. doi: 10.1016/j.jpsychires.2024.02.012. [DOI] [PubMed] [Google Scholar]
  • 28.Ramos-Galarza C., Pérez-Salas C. Inhibitory control and monitoring in child population with ADHD. Av. Psicol. Latinoam. 2017;35:117–130. doi: 10.12804/revistas.urosario.edu.co/apl/a.4195. [DOI] [Google Scholar]
  • 29.Robles F. Attention deficit hyperactivity disorder: Neuropsychological profile and study of its impact on executive functions and academic performance. An. Pediatr. 2024;100:87–96. doi: 10.1016/j.anpedi.2023.11.007. [DOI] [PubMed] [Google Scholar]
  • 30.Gómez-Castrillón A.L., Gómez-Botero M., Molina-González D., Restrepo J.E. Funciones ejecutivas de niños con trastorno por déficit de atención e hiperactividad con o sin epilepsia rolándica benigna. Rev. Chil. Neuropsiquiatr. 2023;61:43–51. doi: 10.4067/S0717-92272023000100043. [DOI] [Google Scholar]
  • 31.Li Y., Zhang L. Efficacy of Cognitive Behavioral Therapy Combined with Pharmacotherapy Versus Pharmacotherapy Alone in Adult ADHD: A Systematic Review and Meta-Analysis. J. Atten. Disord. 2023;28:279–292. doi: 10.1177/10870547231214969. [DOI] [PubMed] [Google Scholar]
  • 32.Arksey H., O’Malley L. Scoping studies: Towards a methodological framework. Int. J. Soc. Res. Methodol. 2005;8:19–32. doi: 10.1080/1364557032000119616. [DOI] [Google Scholar]
  • 33.Eizaguirre M.A.V., Aróstegui J.A.I. Outreach and limitations of the pharmacological treatment of Attention Deficit Disorder with Hyperactivity (ADHD) in children and adolescents and Clinical Practice Guidelines. A literature review. Rev. Asoc. Esp. Neuropsiquiatr. 2014;34:37–74. doi: 10.4321/s0211-57352014000100004. [DOI] [Google Scholar]
  • 34.Rodríguez A.M.V. Controversies between parents and teachers of children and adolescents in Bogotá against the pharmacological treatment of ADHD. Rev. Iberoam. Psicol. 2020;13:13–24. doi: 10.33881/2027-1786.rip.13202. [DOI] [Google Scholar]
  • 35.Ramos-Galarza C., Pérez-Salas C. Psychometric properties:ADHD Rating Scale IV self-report. Revista Chilena de Neuro-psiquiatría. 2016;54:9–18. doi: 10.4067/S0717-92272016000100002. [DOI] [Google Scholar]
  • 36.Hall G.C.N., Ibaraki A.Y., Huang E.R., Marti C.N., Stice E. A Meta-Analysis of Cultural Adaptations of Psychological Interventions. Behav. Ther. 2016;47:993–1014. doi: 10.1016/j.beth.2016.09.005. [DOI] [PubMed] [Google Scholar]
  • 37.Safren S. Cognitive-Behavioral Approaches to ADHD Treatment in Adulthood. J. Clin. Psychiatry. 2006;67:46–50. [PubMed] [Google Scholar]
  • 38.Dittner A.J., Hodsoll J., Rimes K.A., Russell A.J., Chalder T. Cognitive–behavioural therapy for adult attention-deficit hyperactivity disorder: A proof of concept randomised controlled trial. Acta Psychiatr. Scand. 2017;137:125–137. doi: 10.1111/acps.12836. [DOI] [PubMed] [Google Scholar]
  • 39.Lambez B., Harwood-Gross A., Golumbic E.Z., Rassovsky Y. Non-pharmacological interventions for cognitive difficulties in ADHD: A systematic review and meta-analysis. J. Psychiatr. Res. 2019;120:40–55. doi: 10.1016/j.jpsychires.2019.10.007. [DOI] [PubMed] [Google Scholar]
  • 40.Nimmo-Smith V., Merwood A., Hank D., Brandling J., Greenwood R., Skinner L., Law S., Patel V., Rai D. Non-pharmacological interventions for adult ADHD: A systematic review. Psychol. Med. 2020;50:529–541. doi: 10.1017/S0033291720000069. [DOI] [PubMed] [Google Scholar]
  • 41.Jaquerod M.E., Mesrobian S.K., Villa A.E.P., Bader M., Lintas A. Early Attentional Modulation by Working Memory Training in Young Adult ADHD Patients during a Risky Decision-Making Task. Brain Sci. 2020;10:38. doi: 10.3390/brainsci10010038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Arrigoni E., Antoniotti P., Bellocchio V., Veronelli L., Corbo M., Pisoni A. Neural alterations underlying executive dysfunction in Parkinson’s disease: A systematic review and coordinate-based meta-analysis of functional neuroimaging studies. Ageing Res. Rev. 2024;95:102207. doi: 10.1016/j.arr.2024.102207. [DOI] [PubMed] [Google Scholar]
  • 43.Che J., Cheng N., Jiang B., Liu Y., Liu H., Li Y., Liu H. Executive function measures of participants with mild cognitive impairment: Systematic review and meta-analysis of event-related potential studies. Int. J. Psychophysiol. 2024;197:112295. doi: 10.1016/j.ijpsycho.2023.112295. [DOI] [PubMed] [Google Scholar]
  • 44.Garland S.N., Tulk J., Rodriguez N., Rash J.A., Fawcett J.M., McCarthy J., Seal M., Laing K. Perceived Executive Functioning Deficits After Diagnosis in Women with Non-Metastatic Breast Cancer Prior to Adjuvant Therapies. Int. J. Behav. Med. 2023;31:31–40. doi: 10.1007/s12529-023-10153-6. [DOI] [PubMed] [Google Scholar]
  • 45.Gies L.M., Lynch J.D., Bonanno K., Zhang N., Yeates K.O., Taylor H.G., Wade S.L. Differences between parent- and teacher-reported executive functioning behaviors after traumatic injuries. Child Neuropsychol. 2024;13:1–12. doi: 10.1080/09297049.2024.2314957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Hu Y., Li G., Zhang W., Wang J., Ji W., Yu J., Han Y., Cui G., Wang H., Manza P., et al. Obesity is associated with alterations in anatomical connectivity of frontal-corpus callosum. Cereb. Cortex. 2024;34:bhae014. doi: 10.1093/cercor/bhae014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Lage C., Smith E.S., Lawson R.P. A meta-analysis of cognitive flexibility in autism spectrum disorder. Neurosci. Biobehav. Rev. 2024;157:105511. doi: 10.1016/j.neubiorev.2023.105511. [DOI] [PubMed] [Google Scholar]
  • 48.Martínez N.F.L., Pérez-Salas C.P., Barahona C.R., Galarza C.R. Executive Functions in Children with Language Disorder: Some Background from Neuropsychology. Av. Psicol. Latinoam. 2018;36:388–402. doi: 10.12804/revistas.urosario.edu.co/apl/a.5609. [DOI] [Google Scholar]
  • 49.Peña R.R., Pino M., Contreras J. Neuropsychological Assessment in Schooled Adolescent Offenders and Non-Offenders. Int. J. Educ. Psychol. 2024;13:45–62. doi: 10.17583/ijep.12741. [DOI] [Google Scholar]
  • 50.Sakai K., Hosoi Y., Tanabe J. Intervention and assessment of executive dysfunction in patients with stroke: A scoping review. PLoS ONE. 2024;19:e0298000. doi: 10.1371/journal.pone.0298000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Weibel S., Menard O., Ionita A., Boumendjel M., Cabelguen C., Kraemer C., Micoulaud-Franchi J.-A., Bioulac S., Perroud N., Sauvaget A., et al. Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults. Enceph. Psychiatr. Clin. Biol. Ther. 2019;46:30–40. doi: 10.1016/j.encep.2019.06.005. [DOI] [PubMed] [Google Scholar]
  • 52.Sanchez-Gistau V., Manzanares N., Cabezas A., Sole M., Algora M., Vilella E. Clinical and cognitive correlates of childhood attention-deficit/hyperactivity disorder in first-episode psychosis: A controlled study. Eur. Neuropsychopharmacol. 2020;36:90–99. doi: 10.1016/j.euroneuro.2020.05.010. [DOI] [PubMed] [Google Scholar]
  • 53.Halmøy A., Ring A.E., Gjestad R., Møller M., Ubostad B., Lien T., Munkhaugen E.K., Fredriksen M. Dialectical behavioral therapy-based group treatment versus treatment as usual for adults with attention-deficit hyperactivity disorder: A multicenter randomized controlled trial. BMC Psychiatry. 2022;22:738. doi: 10.1186/s12888-022-04356-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Santiago-Rodríguez M.E., Ramer J.D., Marquez D.X., Frazier S.L., Davis C.L., Bustamante E.E. Device-Based Movement Behaviors, Executive Function, and Academic Skills among African American Children with ADHD and Disruptive Behavior Disorders. Int. J. Environ. Res. Public Health. 2022;19:4032. doi: 10.3390/ijerph19074032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Morell B.R., Expósito S.H. Differential long-term medication impact on executive function and delay aversion in ADHD. Appl. Neuropsychol. Child. 2019;8:140–157. doi: 10.1080/21622965.2017.1407653. [DOI] [PubMed] [Google Scholar]
  • 56.Sun T.H., Yeom J.W., Choi K.-Y., Kim J.-L., Lee H.-J., Kim H.-J., Cho C.-H. Potential effectiveness of digital therapeutics specialized in executive functions as adjunctive treatment for clinical symptoms of attention-deficit/hyperactivity disorder: A feasibility study. Front. Psychiatry. 2023;14:1169030. doi: 10.3389/fpsyt.2023.1169030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Makkar M., Arumugam N., Midha D., Sandhu A. Transcranial Direct Current Stimulation as an Effective Treatment Compared to Video Games on Executive Functions in Children with Attention Deficit Hyperactivity Disorder. Iran. Rehabil. J. 2022;20:199–208. doi: 10.32598/irj.20.2.1552.1. [DOI] [Google Scholar]
  • 58.Pheh K.-S., Tan K.-A., Ibrahim N., Sidik S.M. Effectiveness of Online Mindfulness-Based Intervention (iMBI) on Inattention, Hyperactivity–Impulsivity, and Executive Functioning in College Emerging Adults with Attention-Deficit/Hyperactivity Disorder: A Study Protocol. Int. J. Environ. Res. Public Health. 2021;18:1257. doi: 10.3390/ijerph18031257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Chu L., Zhu P., Ma C., Pan L., Shen L., Wu D., Wang Y., Yu G. Effects of Combing Group Executive Functioning and Online Parent Training on School-Aged Children With ADHD: A Randomized Controlled Trial. Front. Pediatr. 2022;9:813305. doi: 10.3389/fped.2021.813305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Rosenau P.T., Openneer T.J.C., Matthijssen A.M., van de Loo-Neus G.H.H., Buitelaar J.K., Hoofdakker B.J.v.D., Hoekstra P.J., Dietrich A. Effects of methylphenidate on executive functioning in children and adolescents with ADHD after long-term use: A randomized, placebo-controlled discontinuation study. J. Child Psychol. Psychiatry. 2021;62:1444–1452. doi: 10.1111/jcpp.13419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Sari S.A., Ulger D., Ersan S., Bakir D., Cicek A.U., Ismailoglu F. Effects of agmatine, glutamate, arginine, and nitric oxide on executive functions in children with attention deficit hyperactivity disorder. J. Neural Transm. 2020;127:1675–1684. doi: 10.1007/s00702-020-02261-4. [DOI] [PubMed] [Google Scholar]
  • 62.Pan M.-R., Zhang S.-Y., Qiu S.-W., Liu L., Li H.-M., Zhao M.-J., Dong M., Si F.-F., Wang Y.-F., Qian Q.-J. Efficacy of cognitive behavioural therapy in medicated adults with attention-deficit/hyperactivity disorder in multiple dimensions: A randomised controlled trial. Eur. Arch. Psychiatry Clin. Neurosci. 2021;272:235–255. doi: 10.1007/s00406-021-01236-0. [DOI] [PubMed] [Google Scholar]
  • 63.Roselló B., Berenguer C., Baixauli I., Mira A., Martinez-Raga J., Miranda A. Empirical examination of executive functioning, ADHD associated behaviors, and functional impairments in adults with persistent ADHD, remittent ADHD, and without ADHD. BMC Psychiatry. 2020;20:134. doi: 10.1186/s12888-020-02542-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Miklós M., Futó J., Komáromy D., Balázs J. Executive Function and Attention Performance in Children with ADHD: Effects of Medication and Comparison with Typically Developing Children. Int. J. Environ. Res. Public Health. 2019;16:3822. doi: 10.3390/ijerph16203822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Andersen A.C., Sund A.M., Thomsen P.H., Lydersen S., Haugan A.-L.J., Nøvik T.S. Executive function measured by BRIEF in adolescents diagnosed and treated for ADHD: Problem profiles and agreement between informants. Child Neuropsychol. 2023;30:45–59. doi: 10.1080/09297049.2023.2174506. [DOI] [PubMed] [Google Scholar]
  • 66.Faraone S.V., Gomeni R., Hull J.T., Busse G.D., Melyan Z., Rubin J., Nasser A. Executive Function Outcome of Treatment with Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Post-Hoc Analysis of Four Randomized Clinical Trials. Pediatr. Drugs. 2021;23:583–589. doi: 10.1007/s40272-021-00470-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Schena A., Garotti R., D’alise D., Giugliano S., Polizzi M., Trabucco V., Riccio M.P., Bravaccio C. IAmHero: Preliminary Findings of an Experimental Study to Evaluate the Statistical Significance of an Intervention for ADHD Conducted through the Use of Serious Games in Virtual Reality. Int. J. Environ. Res. Public Health. 2023;20:3414. doi: 10.3390/ijerph20043414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Solanto M.V., Scheres A. Feasibility, Acceptability, and Effectiveness of a New Cognitive-Behavioral Intervention for College Students with ADHD. J. Atten. Disord. 2020;25:2068–2082. doi: 10.1177/1087054720951865. [DOI] [PubMed] [Google Scholar]
  • 69.Brown T.E., Chen J., Robertson B. Improved Executive Function in Adults Diagnosed with Attention-Deficit/Hyperactivity Disorder as Measured by the Brown Attention-Deficit Disorder Scale Following Treatment with SHP465 Mixed Amphetamine Salts Extended-Release: Post Hoc Analyses From 2 Randomized, Placebo-Controlled Studies. J. Atten. Disord. 2020;26:256–266. doi: 10.1177/1087054720961819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Chen J. Impacts of soccer on executive function in boys with ADHD. Rev. Bras. Med. Esporte. 2023;29:e2022_0469. doi: 10.1590/1517-8692202329012022_0469. [DOI] [Google Scholar]
  • 71.LeBlond E., Smith-Paine J., Riemersma J.J., Horn P.S., Wade S.L., Kurowski B.G. Influence of Methylphenidate on Long-Term Neuropsychological and Everyday Executive Functioning After Traumatic Brain Injury in Children with Secondary Attention Problems. J. Int. Neuropsychol. Soc. 2019;25:740–749. doi: 10.1017/S1355617719000444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Valero M., Cebolla A., Colomer C. Mindfulness Training for Children with ADHD and Their Parents: A Randomized Control Trial. J. Atten. Disord. 2021;26:755–766. doi: 10.1177/10870547211027636. [DOI] [PubMed] [Google Scholar]
  • 73.Torun Y.T., Taner Y.I., Güney E., Iseri E. Osmotic Release Oral System-Methylphenidate Hydrochloride (OROS-MPH) versus atomoxetine on executive function improvement and clinical effectiveness in ADHD: A randomized controlled trial. Appl. Neuropsychol. Child. 2020;11:567–578. doi: 10.1080/21622965.2020.1796667. [DOI] [PubMed] [Google Scholar]
  • 74.Kouhbanani S.S., Rothenberger A. Perceptual-Motor Skills Reconstruction Program Improves Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder. Sustainability. 2021;13:6210. doi: 10.3390/su13116210. [DOI] [Google Scholar]
  • 75.Frisch C., Tirosh E., Rosenblum S. Parental Occupation Executive Training (POET): An Efficient Innovative Intervention for Young Children with Attention Deficit Hyperactive Disorder. Phys. Occup. Ther. Pediatr. 2019;40:47–61. doi: 10.1080/01942638.2019.1640336. [DOI] [PubMed] [Google Scholar]
  • 76.Sun F., Chow G.C.-C., Yu C.C.-W., Ho Y.-F., Liu D., Wong S.H.-S., Siu P.M.-F., Cooper S.B., Jenkins D. Effect of game-based high-intensity interval training program on the executive function of children with ADHD: Protocol of a randomized controlled trial. PLoS ONE. 2022;17:e0272121. doi: 10.1371/journal.pone.0272121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.van der Donk M.L.A., Hiemstra-Beernink A.-C., Tjeenk-Kalff A.C., van der Leij A., Lindauer R.J.L. Predictors and Moderators of Treatment Outcome in Cognitive Training for Children With ADHD. J. Atten. Disord. 2016;24:1914–1927. doi: 10.1177/1087054716632876. [DOI] [PubMed] [Google Scholar]
  • 78.Lan Y.-T., Liu X.-P., Fang H.-S. Randomized control study of the effects of executive function training on peer difficulties of children with attention-deficit/hyperactivity disorder C subtype. Appl. Neuropsychol. Child. 2018;9:41–55. doi: 10.1080/21622965.2018.1509003. [DOI] [PubMed] [Google Scholar]
  • 79.Çelik H.E.A., Küçükgöncü S., Erdoğan A., Özerdem A. Response Inhibition and Interference Control in Adult Attention Deficit Hyperactivity Disorder. Noro Psikiyatr. Arsivi. 2022;60:3–8. doi: 10.29399/npa.28192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Berger I., Dakwar-Kawar O., Grossman E.S., Nahum M., Kadosh R.C. Scaffolding the attention-deficit/hyperactivity disorder brain using transcranial direct current and random noise stimulation: A randomized controlled trial. Clin. Neurophysiol. 2021;132:699–707. doi: 10.1016/j.clinph.2021.01.005. [DOI] [PubMed] [Google Scholar]
  • 81.Iwanami A., Saito K., Fujiwara M., Okutsu D., Ichikawa H. Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: An open-label, long-term, phase 3 extension study. BMC Psychiatry. 2020;20:485. doi: 10.1186/s12888-020-02867-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Qian Y., Liu Y., Jiang W., Zhao Z., Li Y., Chen J., Du Y. Randomized controlled study on the effect of multimodal therapy and drug therapy on children with attention deficit hyperactivity disorder. Zhongguo Ertong Baojian Zazhi. 2020;28:395–398. doi: 10.11852/zgetbjzz2019-1488. [DOI] [Google Scholar]
  • 83.Girard-Lapointe J., Normandeau S., Hechtman L. Moderating Role of Individual and Familial Characteristics in the Improvement of Organizational Skills Following ADHD Youths’ Participation in the TRANSITION Project. Sch. Ment. Health. 2023;16:66–80. doi: 10.1007/s12310-023-09618-6. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.


Articles from Journal of Clinical Medicine are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES